Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

Полное описание

Библиографические подробности
Главные авторы:	Onakpoya, I, Heneghan, C, Aronson, J
Формат:	Journal article
Язык:	English
Опубликовано:	BioMed Central 2016

Схожие документы

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
по: Onakpoya, I, и др.
Опубликовано: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
по: Onakpoya, IJ, и др.
Опубликовано: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
по: Onakpoya, I, и др.
Опубликовано: (2016)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
по: Onakpoya, I, и др.
Опубликовано: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
по: Onakpoya, I
Опубликовано: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
по: Onakpoya, I, и др.
Опубликовано: (2017)

Pharmacogenetics and adverse drug reactions
по: Ferner, R, и др.
Опубликовано: (2010)

An agenda for research on adverse drug reactions.
по: Aronson, J
Опубликовано: (2007)

Adverse drug reactions--no farewell to harms.
по: Aronson, J
Опубликовано: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
по: Aronson, J
Опубликовано: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
по: Edwards, I, и др.
Опубликовано: (2000)

Adverse drug reactions: keeping up to date.
по: Aronson, J, и др.
Опубликовано: (2002)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
по: Aronson, J
Опубликовано: (2017)

Paradoxical reactions: Under-recognized adverse effects of drugs?
по: Hauben, M, и др.
Опубликовано: (2006)

National differences in publishing papers on adverse drug reactions.
по: Ferner, R, и др.
Опубликовано: (2005)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
по: Aronson, J
Опубликовано: (2013)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
по: Loke, Y, и др.
Опубликовано: (2006)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
по: Onakpoya, IJ, и др.
Опубликовано: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
по: Aronson, Jeffrey K.
Опубликовано: (2006)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
по: Aronson, J
Опубликовано: (2012)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
по: Onakpoya, I, и др.
Опубликовано: (2018)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
по: Talbot, J, и др.
Опубликовано: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
по: Talbot, J, и др.
Опубликовано: (2012)

Joining the DoTS: new approach to classifying adverse drug reactions.
по: Aronson, J, и др.
Опубликовано: (2003)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
по: Chun-Bing Chen
Опубликовано: (2023-01-01)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
по: Smith, C, и др.
Опубликовано: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
по: Aronson, J
Опубликовано: (2005)

Adverse Drug Reactions of Cardiovascular Classes of Medicines—Data for Bulgarian Population
по: Zornitsa Mitkova, и др.
Опубликовано: (2024-09-01)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
по: Talbot, J. C. C., и др.
Опубликовано: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
по: McDowell, SE, и др.
Опубликовано: (2013)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
по: Aronson, J, и др.
Опубликовано: (2010)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
по: Derry, S, и др.
Опубликовано: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
по: Derry, S, и др.
Опубликовано: (2001)

Lorcaserin in obesity: minimal benefits and ill-defined harms
по: Onakpoya, I, и др.
Опубликовано: (2019)

Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review
по: E. K. Nezhurina, и др.
Опубликовано: (2024-12-01)

Health risks of unknown medicines: evidence from adverse drug reactions in Laos
по: Caillet, C, и др.
Опубликовано: (2016)

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines
по: M. V. Zhuravleva, и др.
Опубликовано: (2018-02-01)

Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies
по: Shanshan Liu, и др.
Опубликовано: (2023-12-01)

Nonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data
по: G. I. Syraeva, и др.
Опубликовано: (2022-02-01)

Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
по: Huadong Ke, и др.
Опубликовано: (2024-10-01)